Cargando…
Induction of retinopathy by fibrillar oxalate assemblies
The formation of metabolite fibrillar assemblies represents a paradigm shift in the study of human metabolic disorders. Yet, direct clinical relevance has been attributed only to metabolite crystals. A notable example for metabolite crystallization is calcium oxalate crystals observed in various dis...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812261/ https://www.ncbi.nlm.nih.gov/pubmed/36703385 http://dx.doi.org/10.1038/s42004-019-0247-8 |
_version_ | 1784863690734960640 |
---|---|
author | Zaguri, Dor Shaham-Niv, Shira Naaman, Efrat Mimouni, Michael Magen, Daniella Pollack, Shirley Kreiser, Topaz Leibu, Rina Rencus-Lazar, Sigal Adler-Abramovich, Lihi Perlman, Ido Gazit, Ehud Zayit-Soudry, Shiri |
author_facet | Zaguri, Dor Shaham-Niv, Shira Naaman, Efrat Mimouni, Michael Magen, Daniella Pollack, Shirley Kreiser, Topaz Leibu, Rina Rencus-Lazar, Sigal Adler-Abramovich, Lihi Perlman, Ido Gazit, Ehud Zayit-Soudry, Shiri |
author_sort | Zaguri, Dor |
collection | PubMed |
description | The formation of metabolite fibrillar assemblies represents a paradigm shift in the study of human metabolic disorders. Yet, direct clinical relevance has been attributed only to metabolite crystals. A notable example for metabolite crystallization is calcium oxalate crystals observed in various diseases, including primary hyperoxaluria. We unexpectedly observed retinal damage among young hyperoxaluria patients in the absence of crystals. Exploring the possible formation of alternative supramolecular organizations and their biological role, here we show that oxalate can form ordered fibrils with no associated calcium. These fibrils inflict intense retinal cytotoxicity in cultured cells. A rat model injected with oxalate fibrils recaptures patterns of retinal dysfunction observed in patients. Antibodies purified from hyperoxaluria patient sera recognize oxalate fibrils regardless of the presence of calcium. These findings highlight a new molecular basis for oxalate-associated disease, and to our knowledge provide the first direct clinical indication for the pathogenic role of metabolite fibrillar assemblies. |
format | Online Article Text |
id | pubmed-9812261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-98122612023-01-10 Induction of retinopathy by fibrillar oxalate assemblies Zaguri, Dor Shaham-Niv, Shira Naaman, Efrat Mimouni, Michael Magen, Daniella Pollack, Shirley Kreiser, Topaz Leibu, Rina Rencus-Lazar, Sigal Adler-Abramovich, Lihi Perlman, Ido Gazit, Ehud Zayit-Soudry, Shiri Commun Chem Article The formation of metabolite fibrillar assemblies represents a paradigm shift in the study of human metabolic disorders. Yet, direct clinical relevance has been attributed only to metabolite crystals. A notable example for metabolite crystallization is calcium oxalate crystals observed in various diseases, including primary hyperoxaluria. We unexpectedly observed retinal damage among young hyperoxaluria patients in the absence of crystals. Exploring the possible formation of alternative supramolecular organizations and their biological role, here we show that oxalate can form ordered fibrils with no associated calcium. These fibrils inflict intense retinal cytotoxicity in cultured cells. A rat model injected with oxalate fibrils recaptures patterns of retinal dysfunction observed in patients. Antibodies purified from hyperoxaluria patient sera recognize oxalate fibrils regardless of the presence of calcium. These findings highlight a new molecular basis for oxalate-associated disease, and to our knowledge provide the first direct clinical indication for the pathogenic role of metabolite fibrillar assemblies. Nature Publishing Group UK 2020-01-03 /pmc/articles/PMC9812261/ /pubmed/36703385 http://dx.doi.org/10.1038/s42004-019-0247-8 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zaguri, Dor Shaham-Niv, Shira Naaman, Efrat Mimouni, Michael Magen, Daniella Pollack, Shirley Kreiser, Topaz Leibu, Rina Rencus-Lazar, Sigal Adler-Abramovich, Lihi Perlman, Ido Gazit, Ehud Zayit-Soudry, Shiri Induction of retinopathy by fibrillar oxalate assemblies |
title | Induction of retinopathy by fibrillar oxalate assemblies |
title_full | Induction of retinopathy by fibrillar oxalate assemblies |
title_fullStr | Induction of retinopathy by fibrillar oxalate assemblies |
title_full_unstemmed | Induction of retinopathy by fibrillar oxalate assemblies |
title_short | Induction of retinopathy by fibrillar oxalate assemblies |
title_sort | induction of retinopathy by fibrillar oxalate assemblies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812261/ https://www.ncbi.nlm.nih.gov/pubmed/36703385 http://dx.doi.org/10.1038/s42004-019-0247-8 |
work_keys_str_mv | AT zaguridor inductionofretinopathybyfibrillaroxalateassemblies AT shahamnivshira inductionofretinopathybyfibrillaroxalateassemblies AT naamanefrat inductionofretinopathybyfibrillaroxalateassemblies AT mimounimichael inductionofretinopathybyfibrillaroxalateassemblies AT magendaniella inductionofretinopathybyfibrillaroxalateassemblies AT pollackshirley inductionofretinopathybyfibrillaroxalateassemblies AT kreisertopaz inductionofretinopathybyfibrillaroxalateassemblies AT leiburina inductionofretinopathybyfibrillaroxalateassemblies AT rencuslazarsigal inductionofretinopathybyfibrillaroxalateassemblies AT adlerabramovichlihi inductionofretinopathybyfibrillaroxalateassemblies AT perlmanido inductionofretinopathybyfibrillaroxalateassemblies AT gazitehud inductionofretinopathybyfibrillaroxalateassemblies AT zayitsoudryshiri inductionofretinopathybyfibrillaroxalateassemblies |